biocon-pharma-gets-final-approval-for-multiple-andas-from-us-fda News in Hindi -1 News Headlines Found

Biocon pharma gets final approval for multiple ANDAs from US FDA
Mumbai, Mar 5 (UNI) Pharma major, Biocon Pharma, has received final approvals from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug applications (ANDAs) for Lenalidomide Capsules and Dasatinib Tablets.
#Biocon pharma gets final approval for multiple ANDAs from US FDA